Global Hansen's Disease Therapeutics Market
As the global economy mends, the 2021 growth of Hansen's Disease Therapeutics will have significa ... Read More
As the global economy mends, the 2021 growth of Enzyme-linked Immunoassay Kit will have significant change from previous year. According to our (LP Information) latest study, the global Enzyme-linked Immunoassay Kit market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Enzyme-linked Immunoassay Kit market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Enzyme-linked Immunoassay Kit market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Enzyme-linked Immunoassay Kit market, reaching US$ million by the year 2028. As for the Europe Enzyme-linked Immunoassay Kit landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Enzyme-linked Immunoassay Kit players cover R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, and BD Biosciences, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Enzyme-linked Immunoassay Kit market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Sandwich ELISA
Indirect ELISA
Competitive ELISA
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Immunology
Infectious Diseases
Cancer
Protein Quantitation
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
R&D Systems
Thermo Fisher Scientific
Ortho Clinical Diagnostics
BD Biosciences
ZEUS Scientific
Bio-Rad Laboratories
ALPCO
Enzo Life Sciences
BioMérieux
Merck
BioLegend
LOEWE Biochemica
Mercodia
Cusabio
Shanghai Kehua Bio-engineering
As the global economy mends, the 2021 growth of Hansen's Disease Therapeutics will have significa ... Read More
As the global economy mends, the 2021 growth of Metformin Hydrochloride API will have significant ... Read More
As the global economy mends, the 2021 growth of Merkel Cell Carcinoma Therapeutics will have sign ... Read More
As the global economy mends, the 2021 growth of Diabetic Foot Ulcer Therapy Product will have sig ... Read More